Joel Simrén

3.2k total citations · 3 hit papers
44 papers, 1.6k citations indexed

About

Joel Simrén is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Joel Simrén has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 19 papers in Psychiatry and Mental health and 16 papers in Neurology. Recurrent topics in Joel Simrén's work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (17 papers) and Traumatic Brain Injury Research (6 papers). Joel Simrén is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (17 papers) and Traumatic Brain Injury Research (6 papers). Joel Simrén collaborates with scholars based in Sweden, United Kingdom and United States. Joel Simrén's co-authors include Henrik Zetterberg, Kaj Blennow, Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero‐Rodriguez, Arvid Edén, Magnus Gisslén, Barbara Borroni, Roberta Ghidoni and Denis S. Smirnov and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Joel Simrén

42 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change

2022 134 citations Denis S. Smirnov, Nicholas J. Ashton et al. Acta Neuropathologica profile →
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease

2023 128 citations Sriram Balusu, Katrien Horré et al. Science profile →
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years

2022 111 citations Joel Simrén, Ulf Andréasson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel Simrén Sweden	21	671	555	514	373	294	44	1.6k
Samir Abu‐Rumeileh Italy	20	489 0.7×	276 0.5×	844 1.6×	607 1.6×	406 1.4×	55	1.7k
Wei Qin China	22	540 0.8×	284 0.5×	355 0.7×	540 1.4×	404 1.4×	89	1.8k
Henrik Zetterberg Sweden	28	1.1k 1.6×	753 1.4×	602 1.2×	640 1.7×	418 1.4×	172	2.5k
Tobias Skillbäck Sweden	18	962 1.4×	740 1.3×	654 1.3×	497 1.3×	403 1.4×	35	1.9k
Valentina Berti Italy	23	847 1.3×	554 1.0×	309 0.6×	388 1.0×	218 0.7×	112	2.5k
Jamie Toombs United Kingdom	16	588 0.9×	332 0.6×	325 0.6×	345 0.9×	185 0.6×	27	1.2k
Karim Farid France	16	365 0.5×	221 0.4×	421 0.8×	126 0.3×	202 0.7×	46	969
Michele Romoli Italy	25	304 0.5×	662 1.2×	759 1.5×	246 0.7×	136 0.5×	115	2.2k
Edith Hofer Austria	20	295 0.4×	435 0.8×	543 1.1×	223 0.6×	304 1.0×	50	1.8k
Lukas Pirpamer Austria	19	264 0.4×	303 0.5×	581 1.1×	261 0.7×	289 1.0×	56	1.8k

Countries citing papers authored by Joel Simrén

Since Specialization

Citations

This map shows the geographic impact of Joel Simrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Simrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Simrén more than expected).

Fields of papers citing papers by Joel Simrén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Simrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Simrén. The network helps show where Joel Simrén may publish in the future.

Co-authorship network of co-authors of Joel Simrén

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Simrén. A scholar is included among the top collaborators of Joel Simrén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Simrén. Joel Simrén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sauer, Mathias, Laia Montoliu‐Gaya, Andréa L. Benedet, et al.. (2025). Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’. Molecular Neurodegeneration. 20(1). 52–52. 1 indexed citations

Barro, Christian, et al.. (2024). Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls. Molecular Psychiatry. 29(8). 2543–2559. 26 indexed citations

Huber, Hanna, Kaj Blennow, Henrik Zetterberg, et al.. (2024). Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings. Alzheimer s & Dementia. 20(4). 2340–2352. 21 indexed citations

Balusu, Sriram, Katrien Horré, Nicola Thrupp, et al.. (2023). MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science. 381(6663). 1176–1182. 128 indexed citations breakdown →

Larsson, Ing‐Marie, Ewa Wallin, Joel Simrén, et al.. (2023). Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19. Scientific Reports. 13(1). 13144–13144. 18 indexed citations

Swarén, Mikael, Joel Simrén, Hanna Huber, & Henrik Zetterberg. (2023). Combining impact monitoring mouthguards and blood biomarkers to monitor head impacts among Muay Thai athletes – A case study. SHILAP Revista de lepidopterología. 2. 100044–100044. 1 indexed citations

Ashton, Nicholas J., Henrik Zetterberg, Kaj Blennow, et al.. (2023). Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration. Neurology. 101(3). e277–e288. 47 indexed citations

Eriksson, Pontus, Joel Simrén, Wagner S. Brum, et al.. (2023). The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevance. Alzheimer s & Dementia. 19(S14).

Kac, Przemysław R., Fernando González‐Ortiz, Joel Simrén, et al.. (2022). Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 65–65. 49 indexed citations

10.

Smirnov, Denis S., Nicholas J. Ashton, Kaj Blennow, et al.. (2022). Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change. Acta Neuropathologica. 143(4). 487–503. 134 indexed citations breakdown →

11.

Rosén, Anders, Mikael Gennser, Andreas Kvarnström, et al.. (2022). Protein tau concentration in blood increases after SCUBA diving: an observational study. European Journal of Applied Physiology. 122(4). 993–1005. 1 indexed citations

12.

Kanberg, Nelly, Joel Simrén, Arvid Edén, et al.. (2021). Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 70. 103512–103512. 109 indexed citations

13.

Heslegrave, Amanda, Nicholas J. Ashton, Thomas K. Karikari, et al.. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine. 290(3). 583–601. 60 indexed citations

14.

Lord, Jodie, Anna Zettergren, Nicholas J. Ashton, et al.. (2021). A genome-wide association study of plasma phosphorylated tau181. Neurobiology of Aging. 106. 304.e1–304.e3. 6 indexed citations

15.

Høgh, Peter, Joel Simrén, Kaj Blennow, et al.. (2021). Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population. Frontiers in Aging Neuroscience. 13. 659898–659898. 14 indexed citations

16.

Rots, Dmitrijs, Joel Simrén, Nicholas J. Ashton, et al.. (2020). Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease. European Journal of Neurology. 28(3). 974–981. 37 indexed citations

17.

Luoto, Teemu M., Justin E. Karr, Kaj Blennow, et al.. (2020). Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults. Frontiers in Neurology. 11. 1054–1054. 59 indexed citations

18.

Benussi, Alberto, Thomas K. Karikari, Nicholas J. Ashton, et al.. (2020). Diagnostic and prognostic value of serum NfL and p-Tau₁₈₁in frontotemporal lobar degeneration. Journal of Neurology Neurosurgery & Psychiatry. 91(9). 960–967. 102 indexed citations

19.

Schéle, Erik, Daniela M. Pfabigan, Joel Simrén, Uta Sailer, & Suzanne L. Dickson. (2020). Ghrelin Induces Place Preference for Social Interaction in the Larger Peer of a Male Rat Pair. Neuroscience. 447. 148–154. 6 indexed citations

20.

Simrén, Joel, Nicholas J. Ashton, Kaj Blennow, & Henrik Zetterberg. (2019). An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead. Current Opinion in Neurobiology. 61. 29–39. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact